Cargando…
20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer
Castration-resistant progression of prostate cancer after androgen deprivation therapies remains the most critical challenge in the clinical management of prostate cancer. Resurgent androgen receptor (AR) activity is an established driver of castration-resistant progression, and upregulation of the...
Autores principales: | Cao, Bo, Qi, Yanfeng, Yang, Yan, Liu, Xichun, Xu, Duo, Guo, Wei, Zhan, Yang, Xiong, Zhenggang, Zhang, Allen, Wang, Alun R., Fu, Xueqi, Zhang, Haitao, Zhao, Lijing, Gu, Jingkai, Dong, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222907/ https://www.ncbi.nlm.nih.gov/pubmed/25375370 http://dx.doi.org/10.1371/journal.pone.0111201 |
Ejemplares similares
-
20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2018) -
Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2021) -
Synergistic production of 20(S)-protopanaxadiol from protopanaxadiol-type ginsenosides by β-glycosidases from Dictyoglomus turgidum and Caldicellulosiruptor bescii
por: Choi, Ji-Hyeon, et al.
Publicado: (2017) -
Computational and experimental characterization of estrogenic activities of 20(S, R)-protopanaxadiol and 20(S, R)-protopanaxatriol
por: Zhang, Tiehua, et al.
Publicado: (2020) -
20(S)-Protopanaxadiol saponins inhibit SKOV3 cell migration
por: LI, BIN, et al.
Publicado: (2016)